Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety evaluation of inhaled isoflurane sedation in head trauma patients
2023-505729-15-00Phase 2Authorised
- Sponsor
- CHU Grenoble Alpes
- Start
- Jun 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of isoflurane in traumatic brain injury (TBI), sponsored by CHU Grenoble Alpes. Planned start Jun 2024; status: authorised.
02
Drugs
isoflurane
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2023-505729-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505729-15-00.